ArticleInternational journal of surgery (London, England)2026

Artificial intelligence-driven pharmacovigilance analysis of polypharmacy and adverse events in breast cancer survivors treated with antidepressants.

Meilian Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.